Li, H., Liu, Q., Chang, D., Li, S., Yang, L., Zhou, P., . . . Xiao, Y. (2023). Identification of NOX4 as a new biomarker in hepatocellular carcinoma and its effect on sorafenib therapy. Biomedicines, 11(8), . https://doi.org/10.3390/biomedicines11082196
Chicago-Zitierstil (17. Ausg.)Li, Hui-Zhou, Qing-Qing Liu, De-Hua Chang, Shu-Xian Li, Long-Tao Yang, Pengyu Zhou, Jiang-Bei Deng, Chang-Hao Huang, und Yu-Dong Xiao. "Identification of NOX4 as a New Biomarker in Hepatocellular Carcinoma and Its Effect on Sorafenib Therapy." Biomedicines 11, no. 8 (2023). https://doi.org/10.3390/biomedicines11082196.
MLA-Zitierstil (9. Ausg.)Li, Hui-Zhou, et al. "Identification of NOX4 as a New Biomarker in Hepatocellular Carcinoma and Its Effect on Sorafenib Therapy." Biomedicines, vol. 11, no. 8, 2023, https://doi.org/10.3390/biomedicines11082196.